Xu, T.; Zhang, J.; Oroujeni, M.; Tretyakova, M.S.; Bodenko, V.; Belousov, M.V.; Orlova, A.; Tolmachev, V.; Vorobyeva, A.; Gräslund, T.
Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2. Pharmaceutics 2022, 14, 522.
https://doi.org/10.3390/pharmaceutics14030522
AMA Style
Xu T, Zhang J, Oroujeni M, Tretyakova MS, Bodenko V, Belousov MV, Orlova A, Tolmachev V, Vorobyeva A, Gräslund T.
Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2. Pharmaceutics. 2022; 14(3):522.
https://doi.org/10.3390/pharmaceutics14030522
Chicago/Turabian Style
Xu, Tianqi, Jie Zhang, Maryam Oroujeni, Maria S. Tretyakova, Vitalina Bodenko, Mikhail V. Belousov, Anna Orlova, Vladimir Tolmachev, Anzhelika Vorobyeva, and Torbjörn Gräslund.
2022. "Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2" Pharmaceutics 14, no. 3: 522.
https://doi.org/10.3390/pharmaceutics14030522
APA Style
Xu, T., Zhang, J., Oroujeni, M., Tretyakova, M. S., Bodenko, V., Belousov, M. V., Orlova, A., Tolmachev, V., Vorobyeva, A., & Gräslund, T.
(2022). Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2. Pharmaceutics, 14(3), 522.
https://doi.org/10.3390/pharmaceutics14030522